NCT06994117|Unknown
Expanded Access for Mezigdomide
2 other identifiers
CA057-1024CA057-1070
Study Type
expanded_access
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredMay 2025
Brief Summary
This is an expanded access designed to provide access to Mezigdomide for eligible participants.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2025
Completed10 days until next milestone
First Posted
Study publicly available on registry
May 29, 2025
CompletedLast Updated
December 11, 2025
Status Verified
December 1, 2025
First QC Date
May 19, 2025
Last Update Submit
December 10, 2025
Interventions
Eligibility Criteria
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
Study Officials
- STUDY DIRECTOR
Bristol-Myers Squibb
Bristol-Myers Squibb
Central Study Contacts
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
First line of the email MUST contain the NCT# and Site #.
CONTACT
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2025
First Posted
May 29, 2025
Last Updated
December 11, 2025
Record last verified: 2025-12